A biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, temozolomide (Temodal), interferon-alfa and interleukin-2 for metastatic melanoma: A phase II study

Ilan G. Ron*, David Sarid, Larisa Ryvo, Einat Even Sapir, Shlomo Schneebaum, Ur Metser, Noam Asna, Moshe J. Inbar, Tamar Safra

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, temozolomide (Temodal), interferon-alfa and interleukin-2 for metastatic melanoma: A phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences